Back to top
November
4
2015

Exciting European Immunotherapy News

French Sanofi and German BioNTech AG have partnered up to develop up to five immunotherapies for the treatment of cancer. BioNTech’s mRNA technology platform is…

Read More
October
8
2015

Octapharma AG Invests €80 Million

…to acquire an exclusive worldwide license to certain IP of Glycotope’s Recombinant Technology and to become a Minority Shareholder of Glycotope GmbH Berlin LACHEN, Switzerland…

Read More
August
13
2015

Insight 2

Earlier this week, Bristol-Myers Squibb flagged an early success for its Phase III Opdivo (nivolumab) study for kidney cancer, saying that an independent monitoring group…

Read More
July
24
2015

Insight 4

GlaxoSmithKline has been thwarted time and again in its quest to develop a new blockbuster medication. However it has always maintained a high profile in…

Read More
July
23
2015

Insight 5

Tekmira Pharmaceuticals is shifting focus after years of up-and-down development, planning to change its name and train its attention on hepatitis B. The Canadian biotech…

Read More
July
20
2015

Insight 6

Fresh off of completing its spinout from Baxter, Baxalta has unveiled the positive data it’s using to back an approval for BAX 855, a long-acting…

Read More
"Every science begins as philosophy and ends as art." Will Durant,